Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch

Lower Risk in Parous Women Suggests That Hormonal Factors Are Important in Bladder Cancer Etiology

(2011) C. A. Davis-Dao et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Changes in the expression of oestrogen receptors and E-cadherin as molecular markers of progression from normal epithelium to invasive cancer in elderly patients with vulvar squamous cell carcinoma

(2011) Gian F. Zannoni et al.   HISTOPATHOLOGY

Expression of ERβ and Its Co-Regulators p300 and NCoR in Human Transitional Cell Bladder Cancer

(2011) Stylianos Kontos et al.   UROLOGIA INTERNATIONALIS

Impact of gender on bladder cancer incidence, staging, and prognosis

(2011) Harun Fajkovic et al.   WORLD JOURNAL OF UROLOGY

ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading

(2010) Paul Mak et al.   CANCER CELL

Inverse expression of estrogen receptor-β and nuclear factor-κB in urinary bladder carcinogenesis

(2010) Stylianos Kontos et al.   INTERNATIONAL JOURNAL OF UROLOGY

Cadherin Switching and Bladder Cancer

(2010) Richard T. Bryan et al.   JOURNAL OF UROLOGY

Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection

(2010) Mototsugu Muramaki et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Biomarkers for epithelial-mesenchymal transitions

(2009) Michael Zeisberg et al.   JOURNAL OF CLINICAL INVESTIGATION

Roles of estrogen receptor   and   in modulating urothelial cell proliferation

(2008) J. Teng et al.   ENDOCRINE-RELATED CANCER